Stay updated with breaking news from 46433010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) CEO Brett P. Monia sold 32,059 shares of the firm’s stock in a transaction dated Wednesday, January 17th. The stock was sold at an average price of $50.42, for a total value of $1,616,414.78. Following the transaction, the chief executive officer now owns 154,136 shares of the […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) CEO Brett P. Monia sold 32,059 shares of the stock in a transaction dated Wednesday, January 17th. The stock was sold at an average price of $50.42, for a total value of $1,616,414.78. Following the completion of the sale, the chief executive officer now owns 154,136 shares […]
StockNews.com upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) from a sell rating to a hold rating in a research note issued to investors on Wednesday. A number of other equities research analysts have also recently commented on the company. Royal Bank of Canada reissued an outperform rating and issued a $65.00 price objective […]
StockNews.com upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) from a sell rating to a hold rating in a research report sent to investors on Wednesday. IONS has been the topic of several other research reports. Needham & Company LLC reiterated a buy rating and issued a $60.00 price target on shares of Ionis […]
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen brokerages that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation, seven have issued a buy recommendation and one […]